Paid Clinical Trials in Webster, TX

As of September 2026, 65 paid clinical trials are recruiting in Webster, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

64 clinical trials

Get a weekly email when new trials open in Webster, TX.

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

for Metastatic Colorectal Cancer

Drug: Bevacizumab

Sites in Webster, Austin +15 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06820463·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for Myelodysplastic Syndromes

Sites in Webster, Houston +20 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06499285·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Fertilo In Vitro Research Study and Trial

for In Vitro Maturation of Oocytes

Sites in Webster, Austin +13 more locations

Sponsor: Gameto, Inc.

Sex: Female·Age: 18 - 35·Accepts healthy volunteers

Code: NCT06858111·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

for HER2-negative Breast Cancer Patients With Brain Metastases

Sites in Webster, Houston +10 more locations

Sponsor: Biostar Pharma, Inc.

Sex: All·Age: 18+

Code: NCT06764940·Phase 2·Recruiting·Listed Jan 2025

Apply to this trial

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

for SLE

Sites in Webster, Plano +8 more locations

Sponsor: Cullinan Therapeutics Inc.

Sex: All·Age: 18 - 70

Code: NCT06613360·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

for Infertility (IVF Patients)

Sites in Webster, Bedford +14 more locations

Sponsor: Granata Bio Corporation

Sex: Female·Age: 18 - 42

Code: NCT07216742·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

for Atopic Dermatitis

Sites in Webster, Bellaire +4 more locations

Sponsor: Oneness Biotech Co., Ltd.

Sex: All·Age: 18 - 65

Code: NCT06397911·Phase 2·Recruiting·Listed May 2024

Apply to this trial

Reducing Pregnancy Risks: The Mastery Lifestyle Intervention

for Mental Health Wellness 1

1 location in Webster

Sponsor: Microgen LLC

Sex: Female·Age: 18 - 45

Code: NCT05012072·Recruiting·Listed Aug 2021

Apply to this trial

A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

for Superficial Basal Cell Carcinoma

Sites in Webster +2 more locations

Sponsor: MediWound Ltd

Sex: All·Age: 18+

Code: NCT05157763·Phase 1, Phase 2·Recruiting·Listed Dec 2021

Apply to this trial

A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.

for Herpes Zoster (HZ)

Sites in Webster & Houston

Sponsor: Center for Clinical Studies, Texas

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06903078·Recruiting·Listed Mar 2025

Apply to this trial

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

for Plaque Psoriasis

Sites in Webster, Houston +27 more locations

Sponsor: Oruka Therapeutics, Inc.

Sex: All·Age: 18 - 79

Code: NCT07474792·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

for Plaque Psoriasis

Sites in Webster, Houston +20 more locations

Sponsor: Oruka Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07449702·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

for Moderate-to-severe Chronic Plaque Psoriasis

Sites in Webster, San Antonio +8 more locations

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT07362017·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

for Graves Disease

Sites in Webster, DeSoto +9 more locations

Sponsor: Merida Biosciences

Sex: All·Age: 18 - 65

Code: NCT07305818·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)

for Idiopathic Pulmonary Fibrosis (IPF)

Sites in Webster, The Woodlands +8 more locations

Sponsor: PureTech

Sex: All·Age: 40+

Code: NCT07284602·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

for Alopecia Areata

Drug: Ritlecitinib

Sites in Webster, Bellaire +20 more locations

Sponsor: Pfizer

Sex: All·Age: 12+

Code: NCT06873945·Phase 3·Recruiting·Listed Mar 2025

Apply to this trial

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

for Ulcerative Colitis (UC)

Sites in Webster, Houston +28 more locations

Sponsor: Xencor, Inc.

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT06619990·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for HER2-positive Gastric Cancer

Drug: Rilvegostomig

Sites in Webster, Round Rock +44 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06764875·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

for Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Webster, Houston +27 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06350097·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

for Sjögren

Sites in Webster, Plano +4 more locations

Sponsor: Cullinan Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT07041099·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

for Hepatitis B Virus Infection

Sites in Webster, San Antonio +9 more locations

Sponsor: GigaGen, Inc.

Sex: All·Age: 18+

Code: NCT07024641·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Sites in Webster, Houston +53 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 40 - 80

Code: NCT06961214·Phase 3·Recruiting·Listed May 2025

Apply to this trial